- September 27, 2021
- Posted by: Stratford Team
- Category: Business
Press ReleaseNicox First Half 2021 Financial Results and Business Update
- H1 2021 net revenue1 of €1.3 million and cash position of €36.5 million
- NCX 470 NDA submission remains on track
September 27, 2021 – release at 7:30 am CET
Sophia Antipolis, France
Nicox SA (Euronext Paris: FR0013018124, COX), an international ophthalmology company, today reported the financial results for Nicox SA and its subsidiaries (the “Nicox Group”) for the six months ending June 30, 2021 and provided an update on recent events as well as progress on key programs.
First Half 2021 Financial Highlights
Net revenue1 for the first half of 2021 was €1.3 million (including €1.2 million in royalty revenue) versus €2.4 million (including €1.4 million in royalty revenue) for the first half of 2020. Operating expenses for the first half of 2021 were €13.3 million compared to €10.2 million for the first half of 2020.
- The Nicox Group recorded a net loss of €11.7…